Related Experiment Video
Updated: Aug 21, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a
Zongmin Li1, Marlon Jansen, Kenyon Ogburn
1Department of Biological Sciences, Hunter College of City University of New York, New York, New York 10021, USA.
Abstract:
The role of the proinflammatory and inducible form of cyclooxygenases (COX-2) in neurodegeneration is not well defined. Some of its metabolic products, such as prostaglandins (PG) of the J2 series, are known to be neurotoxic. Here we demonstrate that PGJ2 enhances COX-2 gene expression without elevating COX-1 levels in neuronal cells. PGJ2 also increased PGE2 production, establishing that the de novo synthesized COX-2 is enzymatically active. PGJ2 derivatives, such as 15d-PGJ2, are known activators of PPARgamma, a nuclear receptor that activates gene expression. However, the selective PPARgamma agonist ciglitazone failed to up-regulate COX-2, indicating that the PGJ2 effect on COX-2 is PPARgamma independent. Furthermore, PGJ2 stabilized IkappaBalpha levels, indicating that NFkappaB is not active under these conditions. The blocking of neuronal NFkappaB activity by PGJ2 may be an important contributor to its neurotoxicity, insofar as NFkappaB transactivation seems to be required for neuronal survival in the CNS. Interleukin-1 (IL1) is a proinflammatory cytokine known to stimulate the expression of genes associated with inflammation, including COX-2. Notably, IL1 mRNA levels in the neuronal cells were increased by PGJ2 treatment. The proinflammatory cytokine may mediate COX-2 up-regulation by PGJ2 through p38MAPK and not JNK activation, in that only an inhibitor of the former prevented the COX-2 increase. Thiol-reducing agents, such as N-acetylcysteine, protected the neuronal cells from the deleterious effects of PGJ2, whereas ascorbic acid did not. Collectively, our findings suggest that proinflammatory conditions that lead to COX-2 up-regulation and the concomitant production of PGJ2 initiate a mechanism of self-destruction through an autotoxic loop between PGJ2 and COX-2 that may exacerbate neurodegeneration beyond a point of no return. Thiol-reducing antioxidants may offer an optimal strategy for halting this neurodegenerative process.
Insights
Prostaglandin J2 (PGJ2) boosts cyclooxygenase-2 (COX-2) expression in neurons, potentially driving neurodegeneration. Antioxidants like N-acetylcysteine may protect against this self-destructive inflammatory loop.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- The role of cyclooxygenase-2 (COX-2) in neurodegeneration is unclear.
- Prostaglandins (PG) of the J2 series, like PGJ2, are neurotoxic metabolic products.
- Inflammatory processes are implicated in neurodegenerative diseases.
Purpose of the Study:
- To investigate the effect of PGJ2 on COX-2 expression and activity in neuronal cells.
- To elucidate the molecular mechanisms underlying PGJ2-induced COX-2 up-regulation.
- To explore potential therapeutic strategies against PGJ2-mediated neurotoxicity.
Main Methods:
- Neuronal cell culture treated with PGJ2 and its derivatives.
- Measurement of COX-2 and COX-1 gene expression and enzyme activity.
- Analysis of signaling pathways including PPARgamma, NFkappaB, p38MAPK, and JNK.
- Assessment of cell viability using thiol-reducing agents.
Main Results:
- PGJ2 selectively enhanced COX-2 gene expression and activity in neurons, independent of PPARgamma and NFkappaB.
- PGJ2 increased Interleukin-1 (IL1) mRNA levels, suggesting a role for IL1 in the feedback loop.
- COX-2 up-regulation by PGJ2 was mediated by p38MAPK activation.
- N-acetylcysteine, but not ascorbic acid, protected neurons from PGJ2 toxicity.
Conclusions:
- PGJ2 initiates a self-destructive autotoxic loop with COX-2, exacerbating neurodegeneration.
- This loop involves IL1 and p38MAPK signaling.
- Thiol-reducing antioxidants represent a promising therapeutic approach to halt this neurodegenerative process.
Related Concept Videos
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
Two...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...